US › Healthcare

Takeda Pharmaceutical Co Ltd ADR (TAK)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$16.56-1.60%

Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue

$1.22T

Revenue YoY

+10.2%

Net profit

$113.20B

Profit YoY

-8.9%

EPS

$0.48

EPS estimate

$0.41

Net margin

9.3%

EPS came in at 0.48 against a street estimate of 0.41 — a beat of 17.1%.

Key statistics

Market cap

$54.58B

Forward P/E

11.2

P/B

1.18

Book value

$14.36

EPS (TTM)

$-0.32

Dividend yield

3.61%

52-week high

$18.90

52-week low

$12.78

50-day MA

$16.28

200-day MA

$16.27

Beta

0.09

Analyst view

Analysts rate Takeda Pharmaceutical Co Ltd ADR a strong buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $21.77.

Shareholding

Insiders

0.07%

Institutions

3.11%

Largest institutional holders

Fund	Stake
Capital Research Global Investors	0.60%
FMR Inc	0.23%
Morgan Stanley - Brokerage Accounts	0.20%
Adage Capital Partners Gp LLC	0.20%
The Goldman Sachs Group Inc	0.18%
Brandes Investment Partners & Co	0.14%
BlackRock Inc	0.10%
Arrowstreet Capital Limited Partnership	0.10%

Corporate actions

Action	Detail	Date
Dividend	$0.31 / share ex-date Mar 31, 2026 · pay Jul 6, 2026	2026-03-31
Dividend	$0.32 / share ex-date Sep 30, 2025 · pay Dec 11, 2025	2025-09-30

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Takeda Pharmaceutical Co Ltd ADR — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.